| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2297882
Max Phase: Preclinical
Molecular Formula: C24H41Br3N4S
Molecular Weight: 414.66
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Br.Br.Br.CCCN1CCN(c2nc(CCN(C)CCCCCc3ccccc3)cs2)CC1
Standard InChI: InChI=1S/C24H38N4S.3BrH/c1-3-14-27-17-19-28(20-18-27)24-25-23(21-29-24)13-16-26(2)15-9-5-8-12-22-10-6-4-7-11-22;;;/h4,6-7,10-11,21H,3,5,8-9,12-20H2,1-2H3;3*1H
Standard InChI Key: ICCDZPPAJKTZAV-UHFFFAOYSA-N
Associated Targets(non-human)
Histamine H3 receptor 1015 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 414.66 | Molecular Weight (Monoisotopic): 414.2817 | AlogP: 4.56 | #Rotatable Bonds: 12 |
| Polar Surface Area: 22.61 | Molecular Species: BASE | HBA: 5 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 9.14 | CX LogP: 5.76 | CX LogD: 3.52 |
| Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.47 | Np Likeness Score: -1.64 |
References
| 1. Guryn R, Staszewski M, Walczyński K.. (2013) Non-imidazole histamine H3 ligands: part V. synthesis and preliminary pharmacological investigation of 1-[2-thiazol-4-yl- and 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n-propylpiperazine derivatives., 22 (8): [PMID:23807824] [10.1007/s00044-012-0372-8] |
Source
Source(1):